John Wilkin
Stock Analyst at Craig-Hallum
(2.72)
# 1,879
Out of 5,143 analysts
5
Total ratings
60%
Success rate
33.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $4.85 | +147.42% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $19.06 | -21.30% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $43.85 | +2.62% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $11.25 | -28.89% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $6.07 | +377.76% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $4.85
Upside: +147.42%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $19.06
Upside: -21.30%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $43.85
Upside: +2.62%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $11.25
Upside: -28.89%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $6.07
Upside: +377.76%